Biography

Bjørn Christ (Born 1967, Danish citizen) joined Sonova in 2018. He has served Sonova in multiple roles including Strategy, Business development, M&A, Sales Operations and Key account management. He was appointed to Chief Strategy Officer in January 2026.

Bjorn brings 20+ years of international MedTech experience. From 2012 to 2018 he was at Danaher, in commercial executive and general management roles, serving from 2014-2018 as President of Swedish-headquartered IVDfocused operating company HemoCue. Prior to this assignment, Bjorn was at Coloplast as Senior Vice President overseeing the Americas, Asia and Emerging markets, as well as Urology, Wound and Skincare business units. He joined Coloplast from GN ReSound, where he served several years as President of GN ReSound US following 4 years as General Manager, Japan. Bjorn spent his early career in consulting, focusing on information technology at Price Waterhouse and McKinsey & Co. He holds a M.Sc. in Economics (Cand. Polit) from the University of Copenhagen.

Outside mandates

Listed companies:

• n.a.

Other mandates:

• n.a.